Physician

Ghanem Daghestani, MD

According to 2025 Medicare claims, Ghanem Daghestani, MD (NPI: 1295793768) practices hematology/oncology in the McAllen-Edinburg-Mission, TX market, with the plurality of this provider's patient population coming from Hidalgo, TX. This provider's primary affiliated billing organization is TEXAS ONCOLOGY PA (NPI: 1811944101; TIN: 752131429) and primary practice location at 78503-1271. Daghestani is affiliated with the Central Minnesota ACO, LLC (ACO ID: A2844), participating under the MSSP model.

Daghestani's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 238 traditional Medicare patients, billed 47,472 HCPCS/CPT codes, and received $426,343 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 800 prescription claims across 146 beneficiaries totaling $2,080,764 in drug costs, led by Imbruvica (Ibrutinib). 2019 DME data shows 16 claims. Open Payments data shows 18 records totaling $420. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $597,359 and ending at $426,343. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $983,300 and ending at $2,080,764. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.